The MIT MAESTRO study seeks to investigate why some people develop chronic illness from acute infections using the lens of both chronic Lyme and long COVID – while also answering one very important question: Who is likely to develop chronic symptoms after infection and why?

The MAESTRO study will recruit 300 adults aged 18-35 across four distinct cohorts: those with acute Lyme disease, chronic Lyme disease, long COVID, and a control group.

According to the Tal Research Group’s website, “We aim to identify biomarkers that can distinguish individuals who will or will not return to health and to generate actionable information that can advance clinical care, clinical trials, and future therapeutics.”

Click here to learn more about the study and how you can participate.

SOURCE: Tal Research Group, MIT